Triple
T4131814
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | oseltamivir |
E85057
|
entity |
| Predicate | developedBy |
P73
|
FINISHED |
| Object | Gilead Sciences |
E84182
|
NE FINISHED |
How this triple was built (2 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Gilead Sciences | Statement: [oseltamivir, developedBy, Gilead Sciences]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Gilead Sciences Context triple: [oseltamivir, developedBy, Gilead Sciences]
-
A.
Gilead Sciences (board member)
chosen
Gilead Sciences is a major American biopharmaceutical company known for developing antiviral drugs, including treatments for HIV, hepatitis C, and other serious diseases.
-
B.
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals is a leading American biotechnology company known for developing innovative antibody-based therapies for serious diseases, including eye disorders, cancer, and inflammatory conditions.
-
C.
Biogen
Biogen is a major American biotechnology company known for developing therapies for neurological and neurodegenerative diseases.
-
D.
Genentech
Genentech is a pioneering American biotechnology company known for developing groundbreaking therapies and being one of the first firms to apply genetic engineering to medicine.
-
E.
Alkermes
Alkermes is a biopharmaceutical company that develops innovative medicines for central nervous system disorders and other serious chronic diseases.
- F. None of above.
- G. Unsure - the case is ambiguous/there is not enough information to decide.
Provenance (3 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69aed935ccd881909dc61f81bcdb7a78 |
completed | March 9, 2026, 2:29 p.m. |
| NER | Named-entity recognition | batch_69af022f55fc81909f2a1a04d0ea59e6 |
completed | March 9, 2026, 5:23 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69b576c26d4c81909b8be74855cbd03f |
completed | March 14, 2026, 2:54 p.m. |
Created at: March 9, 2026, 3:42 p.m.